Dr. Reddy’s launches generic Evista

HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories on Friday announced the launch of its generic of Evista (raloxifene hydrochloride). 

 

The Dr. Reddy’s generic will be available in 30-, 100- and 1,000-count bottles of 60-mg dosage strength tablets. The drug had $265 million in U.S. sales for the 12 months ended Sepember 2016, according to QuntilesIMS data.